The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells
Journal of Leukocyte Biology · 2023
DOI: 10.1093/jleuko/qiac003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2023. Verfasst von Oscar A Aguilar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of California-San Francisco and Parker Institute for Cancer Immunotherapy, 513 Parnassus Avenue…. Hauptthemen laut MEDLINE: Immunity, Innate, Lymphoma, B-Cell. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Natural killer (NK) cells are innate lymphocytes capable of mediating immune responses without prior sensitization. NK cells express Fc-gamma receptors (FcγRs) that engage the Fc region of IgG. Studies investigating the role of FcγRs on mouse NK cells have been limited due to lack specific reagents. In this study, we characterize the expression and biological consequences of activating mouse NK cells through their FcγRs. We demonstrate that most NK cells express the activating CD16 receptor, and a subset of NK cells also expresses the inhibitory CD32b receptor. Critically, these FcγRs are functional on mouse NK cells and can modulate antibody-mediated responses. We also characterized mice with conditional knockout alleles of Fcgr3 (CD16) or Fcgr2b (CD32b) in the NK and innate lymphoid cell (ILC) lineage. NK cells in these mice did not reveal any developmental defects and were responsive to cross-linking activating NK receptors, cytokine stimulation, and killing of YAC-1 targets. Importantly, CD16-deficient NK cells failed to induce antibody-directed cellular cytotoxicity of antibody-coated B-cell lymphomas in in vitro assays. In addition, we demonstrate the important role of CD16 on NK cells using an in vivo model of cancer immunotherapy using anti-CD20 antibody treatment of B-cell lymphomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of California-San Francisco and Parker Institute for Cancer Immunotherapy, 513 Parnassus Avenue, San Francisco, CA 94143-0414, USA.
- Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
Förderung
- NIAID NIH HHS
- NIH HHS
- NIDDK NIH HHS
- DRC Center
- NIH
Zitieren
APA
Aguilar, O. A., Gonzalez-Hinojosa, M. D. R., Arakawa-Hoyt, J. S., Millan, A. J., Gotthardt, D., Nabekura, T., & Lanier, L. L. (2023). The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiac003
Vancouver
Aguilar OA, Gonzalez-Hinojosa MDR, Arakawa-Hoyt JS, Millan AJ, Gotthardt D, Nabekura T, et al. The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells. Journal of Leukocyte Biology. 2023. doi:10.1093/jleuko/qiac003
BibTeX
@article{Aguilar2023,
author = {Aguilar, Oscar A and Gonzalez-Hinojosa, Maria D R and Arakawa-Hoyt, Janice S and Millan, Alberto J and Gotthardt, Dagmar and Nabekura, Tsukasa and Lanier, Lewis L},
title = {The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells},
journal = {Journal of Leukocyte Biology},
year = {2023},
doi = {10.1093/jleuko/qiac003}
}
EUVIMED